Skip to main content

Neurogene Inc.

NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404644

No open-market purchases or sales by Neurogene Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q3 2026, worth $667.1M in total; no superinvestor holds it.

Holders of 5% or more of NGNE

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Neurogene Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of NGNE
HolderLatest formStakeChangeFirst filedLatest filingFiling
Prudential Financial Inc13G11.20%2.23M sharesNewOct 7, 20261 filingOct 7, 2026SEC
Jennison Associates LLC13G11.10%2.23M sharesNewOct 6, 20261 filingOct 6, 2026SEC
Redmile Group, LLC13G/A9.90%1.57M shares0.00 ppfrom 9.90%Feb 16, 20219 filingsAug 14, 2026SEC
EcoR1 Capital, LLC13G/A9.90%1.44M shares–Feb 16, 20214 filingsNov 14, 2025SEC
Samsara BioCapital, L.P.13G/A9.70%1.95M shares–Feb 14, 20243 filingsNov 16, 2026SEC
RTW Investments, LP13G/A9.30%1.90M shares−0.69 ppfrom 9.99%Nov 14, 20243 filingsNov 16, 2026SEC
Casdin Capital, LLC13G/A8.70%1.30M shares–Nov 8, 20242 filingsFeb 14, 2025SEC
BlackRock, Inc.13G/A6.80%1.01M shares–Apr 23, 20251 filingApr 23, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

65 Schedule 13D and 13G filings on Neurogene Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on NGNE
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 20265:12 PM ETSamsara BioCapital, L.P.and 4 others13G/A9.70%1.95M shares–Sep 30, 2026SEC
Nov 16, 20264:24 PM ETBaker Bros. Advisors LPand 3 others13G/A4.99%1.03M shares−2.01 ppfrom 7.00%Below 5%Sep 30, 2026SEC
Nov 16, 20268:26 AM ETRTW Investments, LPand 1 other13G/A9.30%1.90M shares−0.69 ppfrom 9.99%Sep 30, 2026SEC
Nov 16, 20266:07 AM ETBalyasny Asset Management LLCand 4 others13G/A1.52%304.0K shares−3.66 ppfrom 5.18%Below 5%Sep 30, 2026SEC
Oct 7, 202611:07 AM ETPrudential Financial Inc13G11.20%2.23M sharesNewSep 30, 2026SEC
Oct 6, 20261:49 PM ETJennison Associates LLC13G11.10%2.23M sharesNewSep 30, 2026SEC
Aug 14, 20264:16 PM ETRedmile Group, LLCand 2 others13G/A9.90%1.57M shares0.00 ppfrom 9.90%Jun 30, 2026SEC
Aug 14, 20264:15 PM ETTrails Edge Capital Partners, LPand 2 others13G/A4.50%714.9K shares−0.60 ppfrom 5.10%Below 5%Jun 30, 2026SEC
Aug 14, 20266:05 AM ETBalyasny Asset Management LLCand 4 others13G5.18%818.7K sharesNewJun 30, 2026SEC
Feb 17, 20264:16 PM ETRedmile Group, LLCand 2 others13G/A9.90%1.56M shares0.00 ppfrom 9.90%Dec 31, 2025SEC
Dec 15, 20256:00 PM ETTrails Edge Capital Partners, LPand 2 others13G5.10%785.0K sharesNewDec 8, 2025SEC
Nov 14, 20253:46 PM ETEcoR1 Capital, LLCand 2 others13G/A9.90%1.44M shares–Sep 30, 2025SEC
Aug 14, 20255:07 PM ETCommodore Capital LPand 1 other13G/A3.00%427.9K shares–Below 5%Jun 30, 2025SEC
Aug 14, 20254:27 PM ETBaker Bros. Advisors LPand 3 others13G/A7.00%991.8K shares−2.96 ppfrom 9.96%Jun 30, 2025SEC
May 15, 20254:19 PM ETBaker Bros. Advisors LPand 3 others13G9.96%1.49M shares–Mar 31, 2025SEC
May 12, 202510:36 AM ETFMR LLCand 1 other13G/A3.10%462.9K shares–Below 5%Mar 31, 2025SEC
Apr 23, 20258:57 PM ETBlackRock, Inc.13G/A6.80%1.01M shares–Mar 31, 2025SEC
Feb 14, 20258:01 PM ETRedmile Group, LLCand 2 others13G/A9.90%1.48M shares–Dec 31, 2024SEC
Feb 14, 20254:31 PM ETGreat Point Partners LLCand 2 others13G/A2.98%442.8K shares–Below 5%Dec 31, 2024SEC
Feb 14, 20254:00 PM ETCasdin Capital, LLCand 3 others13G/A8.70%1.30M shares–Dec 31, 2024SEC
Feb 14, 202511:34 AM ETJanus Henderson Group PLC13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 14, 20259:00 AM ETRTW Investments, LPand 1 other13G/A9.99%1.50M shares–Dec 31, 2024SEC
Dec 11, 2024Commodore Capital LP13GOld format–New–SEC
Nov 27, 2024Samsara BioCapital, L.P.13G/AOld format–––SEC
Nov 14, 2024Janus Henderson Group PLC13G/AOld format–––SEC
Nov 14, 2024Great Point Partners LLC13G/AOld format–––SEC
Nov 14, 2024Cormorant Asset Management, LP13G/AOld format–––SEC
Nov 14, 2024RTW Investments, LP13GOld format–New–SEC
Nov 12, 2024FMR LLC13GOld format–New–SEC
Nov 8, 2024Casdin Capital, LLC13GOld format–New–SEC
Jul 8, 20244:36 PM ETBlackRock Inc.13GOld format–––SEC
Feb 14, 2024Janus Henderson Group PLC13GOld format–New–SEC
Feb 14, 2024Great Point Partners LLC13G/AOld format–––SEC
Feb 14, 2024Redmile Group, LLC13G/AOld format–––SEC
Feb 14, 2024Samsara BioCapital, L.P.13GOld format–New–SEC
Feb 14, 2024EcoR1 Capital, LLC13GOld format–––SEC
Feb 14, 2024Cormorant Asset Management, LP13GOld format–New–SEC
Feb 14, 2024Lynx1 Capital Management LP13G/AOld format–––SEC
Dec 27, 2023Great Point Partners LLC13GOld format–New–SEC
Dec 22, 2023Redmile Group, LLC13G/AOld format–––SEC
Dec 21, 2023McMinn Rachel13DOld format–New–SEC
Dec 20, 2023Baker Bros. Advisors LP13D/AOld format–––SEC
Oct 10, 2023Baker Bros. Advisors LP13D/AOld format–––SEC
Aug 17, 2023Baker Bros. Advisors LP13D/AOld format–––SEC
Jul 27, 2023Redmile Group, LLC13DOld format–––SEC
Jul 19, 2023Baker Bros. Advisors LP13D/AOld format–––SEC
Feb 14, 2023Redmile Group, LLC13G/AOld format–––SEC
Feb 3, 2023Pictet Asset Management SA13GOld format–––SEC
Jan 19, 2023Millennium Management LLC13G/AOld format–––SEC
Dec 30, 2022Lynx1 Capital Management LP13GOld format–New–SEC

Form 144: proposed insider sales

8 notices from officers, directors and other affiliates planning to sell Neurogene Inc. shares, newest first.

Form 144 notices for NGNE
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
May 6, 20264:14 PM ETChristine CvijicOfficer14.4K$416.7KMay 6, 202610b5-1J.P. Morgan Securities LLCSEC
Mar 13, 20264:20 PM ETStuart CobbOfficer6.80K$151.6KMar 13, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Feb 27, 20264:51 PM ETChristine CvijicOfficer9.60K$188.9KFeb 27, 202610b5-1J.P. Morgan Securities LLCSEC
May 14, 20254:29 PM ETStuart CobbOfficer6.80K$105.4KMay 14, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Mar 7, 20244:29 PM ETMartin BablerDirector2.50K$98.2KMar 7, 2024Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Mar 4, 20246:20 PM ETSean SmithOfficer371$13.6KMar 4, 2024Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Feb 9, 20244:35 PM ETTodd SimpsonDirector2.50K$77.5KFeb 9, 2024Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Feb 6, 20244:18 PM ETErin LavelleDirector2.50K$76.1KFeb 6, 2024Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC